<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for Frithwood Surgery</h1>
        <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
            explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to: identify unusual prescribing, collect feedback on this prescribing to inform development of new tools to support
            prescribers and organisations to audit and review prescribing.</p>
        <p>The below reports have been developed to use “z-scores” to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. It is important to remember that
            this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical
            method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a> but briefly we calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator.
            We used the time period from April 2021 to August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs. From this we can calculate the “z-score”, which is a measure
            of how many standard deviations a given practice/CCG/PCN is from the population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier
            for prescribing lower than its peers.</p>
        <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=+">survey</a>            or emailing us at
            <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed
            feedback.
        </p>
        <h2>Prescribing where Frithwood Surgery is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L84016&amp;numIds=1202020Q0&amp;denomIds=12.2.2&amp;selectedTab=summary">Xylometazoline hydrochloride/ipratropium bromide</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>2</td>
      <td>Topical nasal decongestants</td>
      <td>15</td>
      <td>0.13</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>123.87</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L84016&amp;numIds=1202020Q0AAAAAA&amp;denomIds=12.2.2&amp;selectedTab=summary" target="_blank">Xylometazoline 70microg/Ipratropium brom 84microg/dose spy : 2</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L84016&amp;numIds=1003020Y0&amp;denomIds=10.3.2&amp;selectedTab=summary">Freeze sprays and gels</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>Rubefacients, topical NSAIDS, capsaicin and poultice</td>
      <td>155</td>
      <td>0.01</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>18.09</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L84016&amp;numIds=1003020Y0BDABAC&amp;denomIds=10.3.2&amp;selectedTab=summary" target="_blank">Deep Freeze Cold Gel 2% : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L84016&amp;numIds=040801020&amp;denomIds=4.8.1&amp;selectedTab=summary">Valproic acid</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>26</td>
      <td>Control of epilepsy</td>
      <td>1005</td>
      <td>0.03</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>13.80</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L84016&amp;numIds=040801020AAACAC&amp;denomIds=4.8.1&amp;selectedTab=summary" target="_blank">Valproic acid 500mg gastro-resistant capsules : 26</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L84016&amp;numIds=0406000AD&amp;denomIds=4.6&amp;selectedTab=summary">Aprepitant</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>2</td>
      <td>Drugs used in nausea and vertigo</td>
      <td>265</td>
      <td>0.01</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>12.47</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L84016&amp;numIds=0406000ADAAAAAA&amp;denomIds=4.6&amp;selectedTab=summary" target="_blank">Aprepitant 80mg capsules : 2</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L84016&amp;numIds=0302000R0&amp;denomIds=3.2&amp;selectedTab=summary">Mometasone furoate</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>8</td>
      <td>Corticosteroids (respiratory)</td>
      <td>1316</td>
      <td>0.01</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>8.72</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L84016&amp;numIds=0302000R0AAAAAA&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Mometasone 200micrograms/dose dry powder inhaler : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L84016&amp;numIds=0302000R0BBAAAA&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Asmanex 200micrograms/dose Twisthaler : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L84016&amp;numIds=0302000R0AAACAC&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Mometasone 400micrograms/dose dry powder inhaler : 4</a></div></td></tr></tbody></table>

        <h2>Prescribing where Frithwood Surgery is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L84016&amp;numIds=0605010S0&amp;denomIds=6.5.1&amp;selectedTab=summary">Somatropin</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Hypothalamic &amp; anterior pituitary hormone &amp; antioestrogens</td>
      <td>3</td>
      <td>0.00</td>
      <td>0.90</td>
      <td>0.27</td>
      <td>-3.31</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L84016&amp;numIds=0106060B0&amp;denomIds=1.6.6&amp;selectedTab=summary">Naloxegol</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>5</td>
      <td>Peripheral opioid-receptor antagonists</td>
      <td>9</td>
      <td>0.56</td>
      <td>0.97</td>
      <td>0.15</td>
      <td>-2.70</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L84016&amp;numIds=0106060B0AAABAB&amp;denomIds=1.6.6&amp;selectedTab=summary" target="_blank">Naloxegol 25mg tablets : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L84016&amp;numIds=0105010B0&amp;denomIds=1.5.1&amp;selectedTab=summary">Mesalazine (Systemic)</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>29</td>
      <td>Aminosalicylates</td>
      <td>113</td>
      <td>0.26</td>
      <td>0.64</td>
      <td>0.15</td>
      <td>-2.61</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L84016&amp;numIds=0105010B0BCADAJ&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Pentasa 1g suppositories : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L84016&amp;numIds=0105010B0AAABAB&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 500mg suppositories : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L84016&amp;numIds=0105010B0AAAJAJ&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 1g suppositories : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L84016&amp;numIds=0105010B0BDADAL&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Salofalk 2g/59ml enema : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L84016&amp;numIds=0105010B0BDAIAJ&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Salofalk 1g suppositories : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L84016&amp;numIds=0105010B0BCAEAN&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Pentasa 1g modified-release granules sachets : 9</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L84016&amp;numIds=0105010B0BCAFAT&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Pentasa 2g modified-release granules sachets : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L84016&amp;numIds=0105010B0BDAKAZ&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Salofalk 3g gastro-resistant modified-release gran sachets : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L84016&amp;numIds=0105010B0BIAAAS&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Octasa 800mg MR gastro-resistant tablets : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L84016&amp;numIds=0105010B0BHAAAR&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mezavant XL 1200mg tablets : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L84016&amp;numIds=1104020T0&amp;denomIds=11.4.2&amp;selectedTab=summary">Sodium cromoglicate</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>11</td>
      <td>Other anti-inflammatory preparations</td>
      <td>56</td>
      <td>0.20</td>
      <td>0.67</td>
      <td>0.18</td>
      <td>-2.58</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L84016&amp;numIds=1104020T0AAAAAA&amp;denomIds=11.4.2&amp;selectedTab=summary" target="_blank">Sodium cromoglicate 2% eye drops : 4</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L84016&amp;numIds=1104020T0BBAEAA&amp;denomIds=11.4.2&amp;selectedTab=summary" target="_blank">Opticrom Allergy 2% eye drops : 7</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L84016&amp;numIds=1310012F0&amp;denomIds=13.10.1&amp;selectedTab=summary">Fusidic acid</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>21</td>
      <td>Antibacterial preparations also used systemically</td>
      <td>56</td>
      <td>0.38</td>
      <td>0.72</td>
      <td>0.15</td>
      <td>-2.27</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=L84016&amp;numIds=1310012F0AAABAB&amp;denomIds=13.10.1&amp;selectedTab=summary" target="_blank">Fusidic acid 2% cream : 21</a></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>